Spark Therapeutics’ vision-loss gene therapy to cost $850000 per patient – Reuters


Wall Street Journal

Spark Therapeutics' vision-loss gene therapy to cost $850000 per patient
Reuters
(Reuters) – Spark Therapeutics Inc said on Wednesday it would charge $850,000 per patient for its gene therapy to treat a rare form of blindness, lesser than analysts' expectation of around $1 million. The company said the list price of the therapy
Spark Therapeutics Sets Price Of Blindness-Curing Gene Therapy At $850000Forbes

all 24 news articles »

Comments

comments

You must be logged in to post a comment Login